At Carleton University, researchers are addressing a growing demand for advanced systems that enable learners to practice ...

The company’s engineering heritage, combined with continuous investment in process automation and digital manufacturing, ...

Overview: Advanced Big data courses equip learners with skills in analytics, machine learning, and data visualization.Hands-on experience with tools like Hadoop ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...

SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...

AI is now a core part of business strategy, and leaders who understand how to use it can make faster decisions, drive ...

Discover how AI is revolutionizing RNA drug development in a new article published in Engineering. Learn about the potential ...

Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...

The seventh installment in a series recapping key sessions from the Data Center Frontier Trends Summit 2025 (Aug. 26–28) in ...

A review paper by scientists at Beijing Institute of Graphic Communication presented  a thorough review of the existing ...